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The Arabidopsis ABC transporter Comatose (CTS;
AtABCD1) is required for uptake into the peroxisome of a wide
range of substrates for -oxidation, but it is uncertain whether
CTS itself is the transporter or if the transported substrates are
free acids or CoA esters. To establish a system for its biochemi-
cal analysis, CTS was expressed in Saccharomyces cerevisiae.
The plant protein was correctly targeted to yeast peroxisomes,
was assembled into the membrane with its nucleotide binding
domains in the cytosol, and exhibited basal ATPase activity that
was sensitive to aluminum fluoride and abrogated by mutation
of a conserved Walker A motif lysine residue. The yeast pxa1
pxa2 mutant lacks the homologous peroxisomal ABC trans-
porter and is unable to grow on oleic acid. Consistent with its
exhibiting a function in yeast akin to that in the plant, CTS res-
cued the oleate growth phenotype of the pxa1 pxa2 mutant,
and restored -oxidation of fatty acids with a range of chain
lengths and varying degrees of desaturation.When expressed in
yeast peroxisomalmembranes, the basal ATPase activity of CTS
could be stimulated by fatty acyl-CoAs but not by fatty acids.
The implications of these findings for the function and substrate
specificity of CTS are discussed.
Peroxisomes perform a range of different functions, includ-
ing -oxidation of fatty acids (FA)2 and synthesis and degrada-
tion of bioactive, lipid-derived molecules. Import of substrates
for peroxisomal metabolism is mediated by ATP binding cas-
sette (ABC) transporters belonging to subclass D (1, 2). ABC
transporters are composed of a minimum of four functional
domains: two transmembrane domains, involved in substrate
binding and translocation, and twonucleotide binding domains
(NBDs) that bind and hydrolyze ATP, providing energy for
transport (3, 4). The domains may be fused into a single
polypeptide, but are frequently expressed as half-size trans-
porters composed of a transmembrane domain fused to an
NBD, which hetero- or homodimerize to form a functional
transporter. Bakers’ yeast (Saccharomyces cerevisiae) contains
two ABCD genes that encode half-size ABC proteins: Pxa1p
(peroxisomal ABC-transporter 1), and Pxa2p (5–7). The single
pxa1 and pxa2 deletion mutants are unable to grow on
oleate (C18:1) as the sole carbon source and exhibit reduced
-oxidation of this long-chain FA. It has been proposed that
Pxa1p and Pxa2p operate as a heterodimer to form a functional
transporter (6, 8, 9), which has been shown by indirect evidence
to be required for the peroxisomal transport of the C18:1-CoA,
a long-chain acyl-CoA ester, but not for import of C8:0-CoA
(10). In contrast,medium-chain FAs enter yeast peroxisomes as
free acids independently of Pxa1p/Pxa2p, and are activated by
peroxisomal acyl-CoA synthetase, Faa2p, prior to -oxidation
(6).
The human ABCD transporter subfamily comprises four
half-size members: adrenoleukodystrophy protein (ALDP),
ALD-related protein, the 70-kDa peroxisomal membrane pro-
tein (PMP70), and PMP70-related protein (PMP70R/PMP69)
(1, 2). Although ALDP, ALD-related protein, and PMP70 have
been implicated in lipid transport across the peroxisomalmem-
brane (2, 11–13), the precise biochemical functions of these
transporters are not well understood. However, ALDP partially
complements the yeast pxa1 pxa2 mutant for growth on
oleate and -oxidation of long-chain FAs (9), suggesting that
ALDP acts as a homodimeric transporter that accepts acyl-CoA
esters (9). In addition, in a study using protease sensitivity as a
probe of conformational changes in ALDP, increased sensitiv-
ity was observed upon addition of long and very long-chain
FA-CoAs but not free FAs (14). Taken together, these studies
suggest a role of ALDP in the transport of very long-chain FA-
CoAs across the peroxisomemembrane, although this hypoth-
esis awaits confirmation by carrying out transport studies in a
reconstituted system.
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The reference plant Arabidopsis thaliana contains a single
peroxisomalABC transporter that has been identified in at least
four independent forward genetic screens and is known as
AtABCD1 (15), CTS (Comatose (16)), AtPXA1 (A. thaliana
peroxisomal ABC transporter 1 (17)), PED3 (peroxisomal
defective 3 (18)), and ACN2 (acetate non-utilizing 2 (19)),
referred to hereafter as CTS. Unlike the yeast and mammalian
peroxisomal ABC proteins, CTS encodes a full-size ABC pro-
tein with two dissimilar halves. Analysis of cts null mutants has
demonstrated that CTS plays key roles in a number of develop-
mental and physiological processes, including germination,
seedling establishment, fertility, root growth, and dark-induced
senescence (16–18, 20–27). The different roles of CTS in
planta are separable by mutagenesis (28) and can be related to
different biochemical roles, specifically the ability tometabolize
distinct substrates such as fatty acids and hormone precursors
via-oxidation. Taken together, these findings strongly suggest
that CTS is a transporter with broad acyl chain specificity,
which mediates uptake of substrates for -oxidation into the
peroxisome. However, this conclusion is based on inferences
from amino acid sequence identity with better characterized
ABC transporters and in vivo mutant phenotypes that can be
pleiotropic. There has been no direct biochemical evidence to
support this interpretation. Additionally, there are arguments
in favor of both acyl-CoAs (16) and free fatty acids as substrates
(29).
Because plant peroxisomes are fragile and difficult to purify
from Arabidopsis seedlings free from mitochondrial contami-
nation, in this paper we have carried out biochemical charac-
terization of heterologously expressed CTS, and provide evi-
dence for its role as a transporter of fatty acyl-CoAs.
EXPERIMENTAL PROCEDURES
Yeast Strains and Culture Conditions—The yeast strains
used in this study are shown in Table 1. Yeast transformants
were selected and grown onminimal mediumwith appropriate
supplements. A single colony of yeast was inoculated into 10ml
of WOYD medium (0.67% (w/v) yeast nitrogen base (BD Bio-
sciences, Oxford, UK), 0.3% (w/v) glucose, 0.1% (w/v) yeast
extract) and incubated at 28 °C for 18 h. For peroxisome prolif-
eration, 5ml of the resultant yeast suspensionwas used to inoc-
ulate a liter of oleate medium (0.5% (w/v) Bacto-peptone, 0.3%
(w/v) yeast extract, 0.12% (v/v) oleic acid, 0.2% (v/v) Tween 20,
0.5% (w/v) KH2PO4, pH 6.0) followed by incubation at 28 °C for
18 h (A600 of 1.0 to 1.5) (30).
Construction of a pxa1Mutant Strain—Gene replacement
was used to generate a BSL1-11 B strain lacking the PXA1 gene.
The KanMX4 disruption cassette was amplified using primers
PXA1KOF (CGTTTCAGACAATCTGGAAGTCTTAGAAC-
GCATAACACAGAAATGGCTTCGTACGCTGCAGGTCG)
and PXA1KOR (ATTATATTCGCTAAATAAAATCTCTCC-
CTTTCTAGGGTGTTTTCACACTATAGGGAGACCGGC-
AGATCC) with plasmid pFA6kanMX4 (31) as template. The
following program was used: 95 °C, 2 min; 30 cycles of 94 °C,
30 s; 60 °C, 30 s; 72 °C, 1 min, followed by a final extension at
72 °C for 5 min. The PCR product was transformed into BSL1-
11B cells and putative pxa1 knockouts were selected on SD
agar supplemented with 500 g/ml of geneticin (G418; Mel-
ford, Ispwich, Suffolk, UK). Following re-streaking on SD-agar
plates containing geneticin, colonieswere inoculated inWOYD
medium for genomic DNA extraction (32). Integration of the
cassette in the correct locus was confirmed by PCR.
Construction of CTS Expression Plasmids—To generate a
construct for expression of CTS in S. cerevisiae, a VspI (blunt)/
EcoRI fragment containing the CTS ORF was ligated into the
SmaI/EcoRI sites of pRS416-GPD (33, 34), to give CTS/
pRS416-GPD. The K487A mutant was generated by site-di-
rected mutagenesis, as described in Dietrich et al. (28). To cre-
ate an in-frame CFP fusion with a 10-amino acid spacer
between the C terminus of CTS and CFP, the native stop codon
of CTS was removed by site-directed mutagenesis using the
QuikChange II site-directed mutagenesis kit (Stratagene, La
Jolla, CA), with primer pair CTSstopF (GAACAGACAACAG-
AGTCAGAATTCGATATCAAGC) and CTSstopR (CTTGT-
CTGTTGTCTCAGTCTTAAGCTATAGTTCG), according
to the manufacturer’s instructions. The removal of the stop
codon and absence of second site mutations were confirmed by
sequencing of the entire CTS coding sequence. CFP was then
amplified using primers CFPsF (AATTGGGGAATTCGGTT-
CAGCAGCTGGATCAGGTGCTAGCGCAATGGTGAGC-
AAGGGCGAGG) andCFPR (CCCAATTGAATTCTTACTT-
GTACAGCACGTCCATGCC), with plasmid pVKh18En6
CFP-SKL (35) as template. The following PCR program was
used: 94 °C, 2 min; 94 °C, 30 s; 65 °C, 30 s; 72 °C, 1 min (30
cycles) plus a final extension for 5 min at 72 °C. The primers
introduced EcoRI restriction sites for subsequent cloning into
CTS/pRS416-GPD linearized with EcoRI. The orientation of
CFP was confirmed by sequencing. To generate a construct for
complementation studies, a BamHI/SalI fragment containing
the CTSORF was excised from the CTS/pRS416-GPD plasmid
and ligated into the BamHI/SalI sites of pEL30 (36), to give
CTS/pEL30. The construction of ALDP/pEL30 is described in
Ref. 9.
Subcellular Fractionation—A light mitochondrial fraction
was prepared essentially according to Ref. 30. Briefly, yeast cells
grown overnight on oleate medium were converted to sphero-
plasts with Zymolase 20T (ICNBiomedicals, Illkirch, France) at
a concentration of 1 mg/g of cells. Spheroplasts were washed
twice inwash buffer (50mMpotassiumphosphate, pH7.5, 1mM
EDTA, 1 mM KCl, 1.2 M sorbitol) before osmotic lysis in break-
ing buffer (5 mM MES, pH 5.5, 1 mM EDTA, 1 mM KCl, 0.65 M
sorbitol) followedbyDounce homogenization. This and all sub-
sequent steps were carried out at 4 °C. Unbroken cells and
nuclei were removed by centrifuging the homogenate twice at
2,000 g for 10 min. The post-nuclear supernatants were fur-
TABLE 1
Yeast strains used in this study
Strain Genotype Source
BSL1- 11B (WT ) MATa, lys20, his4519, Ura30, leu22 Ref. 79
BSL1–11B (pxa1) MATa, lys20, his4519, Ura30, leu22,
YPL147w::kanMX4
This study
BJ1991 (WT ) MAT, leu2, trp1, ura3–251, prb1–1122,
pep4–3
Ref. 9
BJ1991 (pxa1) MAT, leu2, trp1, ura3–251, prb1–1122,
pep4–3 YPL147w::LEU2
Ref. 9
BJ1991(pxa1 pxa2) MAT, leu2, trp1, ura3–251, prb1–1122,
pep4–3 YKL188c::kanMX4;
YPL147w::LEU2
Ref. 9
BJ1991 (fox1) MAT, leu2, trp1, ura3–251, prb1–1122,
pep4–3 (YGL205W::kanMX4)
Ref. 9
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ther centrifuged at 20,000 g for 30min to obtain a light mito-
chondrial fraction (pellet), containing mitochondria and per-
oxisomes. Organelles were purified further by centrifugation
through an iodixanol density gradient. The organelle pellet was
resuspended in 5 ml of homogenization buffer using 2 gentle
strokes with a loose-fitting (Wheaton type B) Dounce homog-
enizer pestle and an equal volume of 47% (w/v) Optiprep (Axis
Shield POC Oslo, Norway) was added. The mixture was care-
fully overlaid on a 2-ml cushion of 35% (w/v) Optiprep and
centrifuged at 110,000 g for 2 h in a swing-out rotor. Homog-
enization buffer and gradient medium contained protease
inhibitors: 1 mM PMSF (Sigma), 1 g/ml of Pefabloc SC
(Sigma) and 1:50 dilution of complete protease inhibitor mix-
ture tablets (Roche Applied Science).
Immunoblotting—Immunoblotting was carried out as de-
scribed in Ref. 16. Dilutions of primary antibodies were as fol-
lows: affinity purified anti-CTS, 1:1,000 (16); anti-thiolase,
1:100 (37); anti-AAC, 1:2,000 (38); anti-SRP72, 1:4,000 (39).
Carbonate and Salt Extractions—A light mitochondrial frac-
tion was prepared as above. The pellet was resuspended in10
volume of hypotonic lysis buffer at 4 °C (10 mM Tris-HCl, pH
8.5, containing 1 mM PMSF, 1 g/ml of Pefabloc SC (Sigma),
and 1:50 dilution of complete protease inhibitormixture tablets
(Roche)). The pellet was disrupted in a Dounce homogenizer
with a tight fitting pestle, using 10 stokes at 4 °C. The mixture
was incubated at 4 °C for 20min followed by homogenization as
above. The mixture was centrifuged at 100,000 g for 1 h at 4 °C
to pellet membranes and the supernatant was collected as the
soluble fraction. The pellet (membrane fraction) was resus-
pended either in salt extraction buffer (1 M NaCl, 10 mM Tris-
HCl, pH 8.5, or 100 mM Na2CO3, pH 11.5, supplemented with
10 mM DTT), to a concentration of 500 g/ml; each solution
contained protease inhibitors. The mixture was homogenized
and incubated at 4 °C for 30 min followed by repeat homogeni-
zation and centrifugation to pellet membrane proteins. The
pellet and supernatant fractions were assayed by SDS-PAGE
and immunoblotting.
Determination of the Orientation of NBDs—A light mito-
chondrial fraction was homogenized in trypsin digestion buffer
(0.65 M sorbitol, 50 mM Tris-HCl buffer, pH 7.5). For protease
protection experiments, reactions contained 100 l of homo-
genate (1 mg/ml of protein) and 0–50 g of trypsin (Sigma), in
the presence or absence of 0.1% (v/v) Triton X-100. Reactions
were incubated on ice for 30 min and the reaction was stopped
by the addition of 200 l of 10 mg/ml of soybean trypsin inhib-
itor (Sigma). The samples were homogenized in10 volume of
0.1 M Na2CO3, pH 11.5, supplemented with 10 mM DTT and
carbonate extraction carried out as above. The pellets and
supernatants were analyzed by immunoblotting with anti-CTS
and anti-thiolase antibodies.
Confocal Microscopy of Yeast Cells—Yeast transformed with
plasmids to co-express CTS-CFP (CTS-CFP/pRS416-GPD)
and YFP-PTS1 (pEW205) was grown in 10 ml of WOYD
medium at 28 °C for 18 h. Cells were harvested by centrifuga-
tion at 5,000  g, and resuspended in 1 ml of water. The sus-
pension was used to inoculate oleatemedium at anA600 of 0.15.
Following growth at 28 °C for 12 h, cells were harvested by
centrifugation at 5,000  g for 5 min, washed in deionized
water, and resuspended inWOYDmedium supplemented with
Mitotracker Orange (Invitrogen) at a final concentration of
12.5 nM.The cellswere incubated at 30 °C for 30min, harvested,
andwashed twice inWOYDmediumpre-warmed to 37 °C. The
cells were mounted in solution containing 90% (v/v) glycerol
and 100 mM Tris-HCl, pH 8.5, and visualized by confocal laser
scanning microscopy. An inverted laser scanning microscope
(LSM 510; Zeiss, Jena, Germany) with argon, HeNe1, diode
lasers, and a63 oil immersion objective was used for confocal
imaging. The pinhole was set to give confocal sections of 1.2
m. Cyan fluorescent protein was excited with a 405-nm laser
and fluorescence was collected through a band pass of 475–525
nm, yellow fluorescent protein was excited at 514 nm, and fluo-
rescence was collected through a band pass of 530–600 nm,
and Mitotracker was excited with a 543 nm laser and fluores-
cence was collected through a band pass filter of 560–615 nm.
All images were scanned using identical conditions (laser
power, gain of photomultiplier tube, pinhole size, and zoom).
Post-acquisition image processing was done using the LSM 5
browser (Zeiss) andAdobe Photoshop 9.0 software (Adobe Sys-
tems, Mountain View, CA).
ATPaseAssays—The basalMg2-dependentATPase activity
of peroxisomes isolated from control yeast and yeast expressing
CTS was determined by measuring the release of inorganic
phosphate from ATP using a colorimetric method (40). The
assay was optimized to be linear with respect to time and
enzyme concentration (peroxisome protein) (supplemental
Fig. S2). Reactions contained 40 mM Tris-HCl, pH 7.4, 0.1 mM
EGTA, 1 mM DTT, 15 mM MgSO4, 10 mM sodium azide, 2 mM
ouabain, 55Mmolybdate, and 10g of peroxisome proteins in
a volume of 95 l. Following equilibration at 37 °C for 10 min,
the reaction was started by the addition of 5 l of Mg-ATP
solution (7 mM MgSO4, 5 mM ATP) and incubated at 37 °C for
20min. Reactionswere stopped by the addition of 100l of 12%
(w/v) SDS, before color development as described (40). Where
indicated, inhibitors (10mMAlFx, (added bymixing an equimo-
lar concentration of aluminum chloride and sodium fluoride),
100 M sodium orthovanadate, or 10 M concanamycin A)
were added to the reaction mixture before allowing the reac-
tants to equilibrate. ATPase activity was also assayed in the
presence of fatty acids (Nu-Chek Prep, Inc., Elysian, MN) or
fatty acyl-CoAs (Avanti Polar Lipids Inc., Alabaster, AL) in the
range of 0 to 1000 M (final concentration). In these assays,
MgSO4 was reduced to 2.5 mM to avoid precipitation of acyl-
CoAs (41, 42). Substrates were solubilized in 5% (w/v) 2-hy-
droxypropylated -cyclodextrin (43) and incubated in the
ATPase reaction mixture at 37 °C for 10 min to equilibrate the
reactants and allow substrate recognition and binding before
starting the reactionwithMgATP as above. Data were analyzed
by one-way or two-way analysis of variance and expressed as
means (nanamole of Pi/mg/min) 95% confidence limit (CL).
The stimulation indices (SI) for different compounds were cal-
culated as (CTS expressing (stimulated) control (stimulated))/
(CTS (unstimulated)  control (unstimulated)). Data were
expressed asmean SI 95%CL, where 95%CLwas determined
according to the formula: 95% CLmean (t S.E.), where
n number of samples, t value of the Student’s t distribution
at (n-1) degrees of freedom and S.E. is the mean  S.E. All
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statistical analysis and calculationswere done using theOrigin
8.0 Data Analysis and Graphing Software statistical package
and WindowsMicrosoft Excel.
Complementation of pxa1 pxa2—Transformed yeast cells
were grown in minimal medium containing 0.67% (w/v) yeast
nitrogen base without amino acids, supplemented with 0.3%
(w/v) glucose and amino acids (20mg/liter), if required, at 28 °C
for 24 h. For the induction of peroxisome proliferation, cells
were shifted to YPOmedium containing 0.5% potassium phos-
phate buffer, pH 6.0, 0.3% (w/v) yeast extract, 0.5% (w/v) pep-
tone supplemented with 0.12% (w/v) oleate and 0.2% (w/v)
Tween 80. Cultures were incubated for 150 h in an orbital
shaker at 200 rpm. TheA600 wasmeasured every 12 h bymixing
100l of culture, 50l of 10% (v/v) Triton X-100, and 850l of
water. Oleic acid plates contained 0.125% (w/v) oleic acid, 0.4%
(w/v) Tween 80, 2% (w/v) agar, 0.67% (w/v) yeast nitrogen base
without amino acids, 0.1% (w/v) yeast extract (Difco) and
amino acids (20 g/ml) as needed. -Oxidation assays in intact
cells were performed as described previously (9) with some
modifications. Cells were grown overnight in medium contain-
ing oleate to induce fatty acid -oxidation. The -oxidation
capacity was measured in 50 mM MES, pH 6.0, supplemented
with 10 M 1-14C-labeled fatty acids. Subsequently, [14C]CO2
was trapped in 2 M NaOH and used to quantify the rate of fatty
acid oxidation.
RESULTS
CTS Is Targeted to the Peroxisome in S. cerevisiae—To deter-
mine the suitability of S. cerevisiae (BSL1-11B) as a heterolo-
gous system for the biochemical characterization of CTS, the
CTS ORF was expressed from a low copy plasmid (pRS416-
GPD) under the control of the strong, constitutive glyceralde-
hyde-3-phosphate dehydrogenase (GPD) promoter (34). To
investigate whether CTS was appropriately targeted in the het-
erologous host, peroxisomes were purified on Iodixanol gradi-
ents from a “light mitochondrial fraction” of oleate-grown cells
transformed with CTS/pRS416-GPD or the non-recombinant
vector, as described (30). Total, cytosolic, and the mitochon-
drial and peroxisomal fractions from the gradient were ana-
lyzed by SDS-PAGE, followed by immunoblotting with specific
antibodies for the peroxisomal marker, thiolase (37), and the
mitochondrial marker, adenine nucleotide carrier (AAC; Ref.
38). Clean separation of mitochondria and peroxisomes was
demonstrated by the absence of the peroxisomal marker from
the mitochondrial fraction, and vice versa (Fig. 1, bottom two
panels). When the fractions were probed with an affinity-puri-
fied antiserum raised to the C-terminal NBD of CTS (16), a
band of the expected size (about 130 kDa) was observed in the
peroxisomal fraction isolated fromcells transformedwithCTS/
pRS416-GPD (Fig. 1,middle panel). A doublet of cross-reacting
bands (CTS*) of about 70 kDa was detected in the peroxisomal
and mitochondrial fractions but was absent from the control
(non-recombinant vector) samples. Further experiments sug-
gested that these bands arose from cleavage between the two
halves of CTS by an endogenous yeast protease (supple-
mental Fig. S1). Cleavage was not prevented in a pep4 knock-
out strain of yeast (data not shown). To provide independent
corroboration of peroxisomal localization, CTS was tagged
with CFP at the C terminus and co-expressed in yeast with
YFP-PTS1, a peroxisomal marker. Peroxisomes were observed
as discrete spots in the YFP channel (Fig. 2B) andmany of these
coincided with the CFP signal (A), as indicated in the merge
panel (C). Cells were also stained with Mitotracker to visualize
mitochondria (E). The Mitotracker and CFP signals did not
co-localize (F), suggesting that there was no significant amount
of CTS present in the mitochondria and that the degradation
products seen in immunoblots of the mitochondrial fraction
could represent association with membranous fragments that
co-fractionate with mitochondrial markers in the gradients.
Membrane Integration and Topology of CTS—As a prerequi-
site to functional testing, the integration and topology ofCTS in
the yeast peroxisomal membrane were next evaluated. A light
mitochondrial fraction (which contains mitochondria and per-
oxisomes, as well as some contaminating endoplasmic reticu-
lum) was subjected to hypotonic lysis and centrifugation, to
provide a membrane and soluble fraction. CTS, its associated
degradation products, and the integral membrane protein
marker, AAC, were detected exclusively in the membrane frac-
tion, whereas the peripheral ERmembrane protein, SRP72 (39),
was partially soluble and partially membrane-associated (Fig.
3). Membranes were resuspended in sucrose buffer, alkaline
sodium carbonate, or high salt and re-centrifuged. CTS, AAC,
and SRP72 all remainedmembrane-associated on resuspension
and re-pelleting in sucrose buffer, but SRP72 was extracted by
both high salt and sodium carbonate showing that, as expected,
these treatments were effective at removing peripheral mem-
brane proteins. Both CTS and AAC were present in the pellets
from the carbonate and salt treatments, indicating that CTS
behaves as an integralmembrane protein. Notably, the cleavage
FIGURE 1. CTS targets to peroxisomes in yeast. A light mitochondrial frac-
tion was prepared from oleate-grown BSL1-11B cells transformed with a CTS
expressionplasmid (CTS/pRS416-GPD) orwith non-recombinant vector (con-
trol) and separated on an Iodixanol density gradient. Mitochondrial and per-
oxisomal fractions from the gradient along with total and cytosolic samples
were separatedby SDS-PAGE (30gof protein/lane), stainedwithCoomassie
Blue (upper panel) or immunoblottedwithantibodies specific forCTS, thiolase
(peroxisomal marker), and mitochondrial AAC (mitochondrial marker). The
mobilities of marker proteins of known mass (kDa) are indicated on the left-
hand side of the figure.
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products were also found in the pellets, indicating that they are
also firmly integrated in the membrane.
Partial proteolysis was used to investigate the topology of
CTS within the peroxisomal membrane. A light mitochondrial
fraction (100 g) was incubated with increasing amounts of
trypsin, then separated intomembrane-bound and soluble frac-
tions and analyzed by immunoblotting with the anti-CTS
C-terminal antiserum, which recognizes both NBDs (44). The
membrane fractions (Fig. 4A) showed that full-length CTS was
very sensitive to proteolysis and was almost completely
degraded following incubation for
30 min at 0 °C with 1% (w/w) tryp-
sin. The endogenous cleavage prod-
ucts were also degraded at higher
trypsin concentrations. Analysis of
the soluble fractions (Fig. 4B)
revealed the presence of a fragment
of the expected size of the NBDs
(about 25 kDa), which was pro-
duced by treatment with 0.5% (w/w)
trypsin but was completely de-
graded at concentrations greater
than 10% (w/w). Under these condi-
tions, thiolase, which is a peroxi-
somalmatrix protein, remained com-
pletely protected from digestion,
unless Triton X-100 was added.
This is consistent with the cleavage
of the NBDs from the membrane at
low concentrations of trypsin and
their degradation at higher concen-
trations. Thus we conclude that the
NBDs face the cytosol. The addition
of 0.1% (v/v) Triton X-100 did not
result in a qualitative change in the
cleavage pattern of themembrane-associated species but rather
accelerated the rate of cleavage, due to the solubilizing effect of
the detergent (not shown).
CTS Exhibits ATPase Activity Which Is Inhibited by AlFx—
To assess the functionality of expressed CTS, the ATPase activ-
itywasmeasured in peroxisomes purified fromCTS-expressing
and control yeast. Initial experiments showed that activity was
linearwith respect to the amount of peroxisomal protein added,
in the range of 0–20g, and linear with respect to time up to 60
min (supplemental Fig. S2, A and B). In wild-type (BSL1-11B)
and pxa1 backgrounds, control peroxisomes had a modest
ATPase activity (black bars) that was not inhibited by ouabain,
azide, concanamycin A, or molybdate (data not shown), but
which was strongly inhibited by AlFx (Fig. 5A, white bars). The
pxa1 knock-out mutant had a similar level of activity to wild-
type yeast, indicating that the background activity was not sub-
stantially contributed by Pxa1/Pxa2p. Expression of CTS in
both wild-type and pxa1 cells gave a 2.5-fold increase in activ-
ity, which was also sensitive to AlFx. The CTS-dependent
ATPase activity was insensitive to sodium orthovanadate (not
shown). Introduction of the NBD1 Walker A motif mutation,
K487A, which abrogates function in planta (28), reduced
ATPase activity to a level similar to that of the control. As a
control, we determined that the mutant was correctly targeted
to the peroxisome and expressed at a similar level to the wild-
type protein (Fig. 5B).
To investigate whether the ATPase activity ascribed to CTS
demonstrated structure-linked latency, theATPase assayswere
carried out both on intact and on osmotically ruptured peroxi-
somes (supplemental Fig. S3). Whereas peroxisomes from cells
expressing CTS showed more than double the activity of the
control, as seen in Fig. 5A, there was no difference in activity
between ruptured and intact peroxisomes. The absence of
FIGURE 2. CTS-CFP targets to peroxisomes in yeast. Yeast strain BLS1-11B cells co-transformed with the
CTS-CFP and YFP-PTS1 expression plasmids were grown on WOYD and transferred to oleate medium. Mito-
chondria were labeled with 12.5 nM Mitotracker and visualized by confocal microscopy, as described under
“Experimental Procedures.” A, CTS-CFP; B, YFP-PTS1; C, merge of A and B; D, differential interference contrast
image; E, Mitotracker; F, Mitotracker and CTS-CFP. E and F are the same group of cells as A and B but a different
optical section. Examples of co-localizations are indicated by arrowheads. Scale bar, 5 m.
FIGURE 3.CTS is an integralmembrane protein in S. cerevisiae.Organelles
(lightmitochondrial fraction)were lysed in ahypotonic buffer in thepresence
of protease inhibitors andmembranes were separated from soluble proteins
by centrifugation at 100,000 g.Membranes were then extracted with alka-
line sodium carbonate buffer, pH 11.5 (carb), 1 M NaCl (salt), or sucrose buffer
(suc), followed by centrifugation at 100,000 g to pellet membranes. Lysate
fractions (total, T; membrane, M; soluble, S) plus pellet (P) and supernatant
fractions (S) were separated by SDS-PAGE (30g/lane) followed by immuno-
blottingwith antibodies raised against CTS, AAC (integral membrane protein
marker), and SRP72 (peripheral membrane protein marker).
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latency is consistent with a cytosolic location of the NBDs as
deduced from partial proteolysis experiments (Fig. 4).
As an independent means of testing CTS functionality, its
ability to bind to ATP-agarose was also tested. Both full-length
CTS and the cleavage products bound to ATP-agarose
(supplemental Fig. S4A) and were eluted with 10 or 20mMATP
(supplemental Fig. S4B), providing confirmation of proper fold-
ing and suggesting that the cleavage products most likely rep-
resent the two CTS halves that remain associated to form com-
posite ATP binding sites, as would occur in the intact
transporter (3, 28).
CTS Complements the Yeast pxa1 pxa2 Mutant—Because
the biochemical data suggested that CTS was functional when
expressed in yeast, we investigated the ability of CTS to com-
plement an S. cerevisiae pxa1 pxa2mutant, for -oxidation of
different fatty acids. TheCTSORFwas subcloned into pEL30, a
yeast expression vector that contains the oleate-inducible cat-
alase promoter and was used successfully for expression of
FIGURE 4. Determination of orientation of NBDs by controlled proteoly-
sis. Aliquots (100 g of protein) of a light mitochondrial fraction were
digested with the quantities of trypsin indicated for 30 min at 0 °C, in the
presence or absence of detergent (Triton X-100). The reactions were
stopped by the addition of soybean trypsin inhibitor and subjected to
carbonate extraction followed by centrifugation at 100,000  g to pellet
the membranes. Pellet and supernatant fractions were separated by SDS-
PAGE, transferred to nitrocellulose, and probed with CTS- or thiolase-spe-
cific antibodies.Mock indicates a reaction in which soybean trypsin inhib-
itor was added before trypsin. A, membrane fraction following tryptic
digestion in the absence of detergent. B, supernatant fraction following
tryptic digestion in the absence (upper two panels) and presence (lower
panel) of Triton X-100.
FIGURE 5. Basal ATPase activity of wild-type CTS and K478Amutant. Per-
oxisomes were isolated from oleate-grown wild-type BSL1-11B or pxa1
mutant yeast (PXA1KO), transformed with vectors encoding CTS, CTSK487A, or
lacking an insert (control). A, ATPase activity was measured in the absence
(black bars) or presence (open bars) of 10 mM AlFx. All samples were analyzed
in triplicate, and the experiment was repeated three times. The data were
used to compute themeans and themeanS.E. Theplot showsmean95%
confidence limit (computed from S.E. for n 9) as indicated by the error bars.
Data were analyzed by two-way analysis of variance, which indicated signifi-
cantly higher ATPase activity of wild-type CTS compared with the K487A
mutant (p 0.05). The difference in the ATPase activity between the control
BSL1–11B and the control pxa1 mutant was insignificant. B, total, cytosol,
peroxisome, and mitochondria fractions were isolated from oleate-grown
BSL1-11B cells (upper panel) orpxa1 cells (lower panel), transformedwith the
indicated constructs. Proteins (30g/lane) were separated by SDS-PAGE and
immunoblotted with a CTS-specific antibody.
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ALDP in S. cerevisiae (9). Peroxisomal targeting of CTS was
confirmed by fractionation of organelles and immunoblotting
(supplemental Fig. S5). Mutant cells transformed with CTS/
pEL30 grew almost as well as thewild-type on oleate plates (Fig.
6A), and somewhat better than cells transformed with the
human peroxisomal ABC transporter, ALDP, in liquidmedium
(Fig. 6B).
CTS Expressing pxa1 pxa2Mutant Yeast Strains Can Oxi-
dize a Wide Range of Fatty Acids—The ability of pxa1 pxa2
mutant cells expressing CTS to metabolize fatty acids of differ-
ent chain length and saturation was tested and compared with
that of cells expressing ALDP (Fig. 7). For each substrate, data
were normalized to the rate of-oxidation forwild-type (WT
BJ1991) cells. WT rates of -oxidation for lauric (C12:0), pal-
mitic (C16:0), stearic (C18:0), oleic (C18:1), linoleic (C18:2),
behenic (C22:0), and docosahexanoic (C22:6) acids were 7.24
0.8, 1.06 0.1, 0.95 0.2, 2.6 0.5, 2.73 0.51, 0.15 0.008,
and 0.62  0.08 nmol/min/OD, respectively, and the rate for
lignoceric (C24:0) was 4.46 0.15 pmol/h/OD. As shown pre-
viously, Pxa1/Pxa2p contribute to -oxidation of fatty acids of
chain lengthC16 or greater, but not to the-oxidation ofC12:0,
as evidenced by the relative level of -oxidation in the pxa1
pxa2 mutant transformed with vector lacking insert (6). For
C16:0 and longer acyl chains, expression of CTS increased
-oxidation above the level seen for the non-recombinant con-
trol vector, restoring -oxidation to 75–80% of the WT level.
The Walker A motif mutant, CTSK487A, did not restore -oxi-
dation, compared with the vector-transformed control. ALDP
was only effective with longer chain substrates of length C22:0
and longer, in agreement with Ref. 9. The -oxidation mutant,
fox1, which lacks acyl-CoA oxidase, did not metabolize any of
the fatty acids tested (Fig. 7). These data support the hypothesis
that CTS has broad substrate specificity with regard to chain
length and degree of desaturation. However, these in vivomea-
surements are constrained by the ability of yeast to metabolize
different fatty acids and only provide indirect evidence for sub-
strate specificity. Therefore we sought alternative, biochemical
evidence for the ability of CTS to accept a range of substrates.
Effects of Potential Substrates on the ATPase Activity of CTS—
The ATPase activity of many ABC transporters is increased
above basal rates upon substrate binding (45–50). Exploiting
this behavior, it is possible to screen a range of compounds to
identify putative substrates for a givenATP transporter. There-
fore we tested the effects of fatty acids and fatty acyl-CoAs on
the ATPase activity of CTS when expressed from the vector
pEL30 in the BJ1991 pxa1 strain. Substrates (10–1000 M)
were solubilized in 5% (w/v) hydroxyl-propylated -cyclodex-
trin. The effects of 10M substrates on activity are presented in
Fig. 8A, black bars indicate activity with CTS; white bars are
non-recombinant vector controls. Control reactions in the
presence of individual assay components (ATP (“ATP only”),
peroxisome extract (“protein only”), FA-CoA (“C-18-CoA
only”), or FA (“C18:1 only”)) showed only a very low rate of
inorganic phosphate production (20 nmol of Pi/min or less). In
the CTS/pEL30-transformed cells, basal ATPase activity was
86.64 2.49 nmol of Pi/min/mg of protein. This was increased
in the presence of all fatty acyl-CoAs tested, although the effects
of fatty acids were marginal (Fig. 8A). CoASH had no effect on
activity, but the non-hydrolyzable C14-etheno-CoA increased
CTS-dependent basal ATPase activity, demonstrating that sim-
ulation of activity by FA-CoA was not due to release of FA by
hydrolysis. Indole butyric acid and 2,4-dichlorophenoxybutyric
acid have both been proposed as substrates of CTS (17, 18), but
these compounds did not stimulate ATPase activity (data not
shown). Unfortunately the corresponding CoA esters could not
be tested as they are not commercially available. No effect of
any of the potential substrates was seen on the ATPase activity
of non-recombinant vector-transformed cells. To evaluate
more precisely the effects of the different compounds, a stimu-
lation index was calculated for each potential substrate, as
defined under “Experimental Procedures.” From this, it is clear
that FA-CoA give a higher stimulation of activity: about 2-fold,
compared with 1.2–1.4-fold for FA (Fig. 8B).
DISCUSSION
Genetic and physiological evidence has indicated that CTS is
involved in the transport of substrates into the peroxisome for
-oxidation but, to date, no direct biochemical data have been
available to support this hypothesis. To address this, we have
expressed CTS in S. cerevisiae, demonstrated that it is correctly
targeted to peroxisomes in the heterologous host, and is inte-
FIGURE 6. CTS complements the S. cerevisiae pxa1 pxa2 mutant for
growth on oleate. Growth of wild-type and mutant cells on solid (A) and
liquid (B) oleate medium. Strains shown are as follows: wild-type (WT;
BJ1991), fox1 (acyl-CoA oxidase deletion mutant; negative control), pxa1
pxa2mutant cells transformedwith CTS/pEL30, ALDP/pEL30, or vector lack-
ing insert (two independent transformants of CTS/pEL30 are shown in B).
Data are representative of at least two independent experiments.
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grated into the peroxisomal membrane in a functional form,
allowing complementation of a pxa1 pxa2mutant.
Through complementary cell fractionation and confocal
microscopy approaches, it was shown that full-length CTS is
targeted to the peroxisome in yeast, which, taken together with
other findings, suggests conservation of targeting of peroxi-
somal membrane proteins between plants, yeast, mammals,
and protozoa (51–54). Attempts to complement a pxa1
mutant with the CTS/pRS416-GPD construct gave inconsis-
tent results (data not shown), suggesting that for complemen-
tation to work effectively either the expression of CTS has to be
coordinated with the proliferation
of peroxisomes (as would be ex-
pected to be the case when CTS
expression is driven from the CAT
promoter of pEL30) or that the
presence of Pxa2p somehow inter-
feres with the function of CTS.
When ALDP (HsABCD1) was co-
expressed with Pxa1p in yeast it
was inactive but like CTS could
complement a pxa1 pxa2mutant
(9).
Carbonate and salt extraction
demonstrated that this protein is
integrated into the yeast peroxi-
somal membrane, consistent with
its behavior as an integral mem-
brane protein in Arabidopsis (18),
and partial proteolysis experiments
indicated that the NBDs face the
cytosol, as has been shown for the
human peroxisomal ABC trans-
porters, ALDP and PMP70 (55, 56).
This topology is consistent with the
canonical model of ATP-dependent
transport of substrates from the
cytosol to the peroxisome lumen
and rules out a model in which CTS
utilizes the peroxisomal pool of
ATP supplied by the adenine nucle-
otide translocators, PNC1 and -2
(57, 58).
We were able to demonstrate
ATPase activity in peroxisomes
purified from cells expressing CTS,
which was consistently 2–3-fold
higher than that of peroxisomes iso-
lated from control cells transformed
with vector lacking insert. Interest-
ingly, the level of control ATPase
activity in the pxa1 knock-out was
not greatly different to that of wild-
type cells, suggesting that the basal
activity of endogenous Pxa1/Pxa2p
is low relative to other ATPases in
the peroxisome fraction. Indepen-
dent confirmation of functionality
was obtained by ATP binding experiments in which full-length
CTS bound to ATP-agarose and could be eluted with ATP.
Expression of CTS bearing a K487A mutation in the Walker A
motif, which abolishes function in planta, reduced peroxisomal
ATPase activity to close to control levels, providing evidence of
specificity. Both control and CTS-dependent ATPase activities
were insensitive to vanadate (Vi), but were inhibited by AlFx.
Vanadate and metal fluorides act as phosphate analogues,
arresting ATP-utilizing enzymes in the catalytic cycle by
forming a stable MgADPinhibitor complex, but ABC trans-
porters differ in their sensitivity to these inhibitors (46, 47, 59,
FIGURE 7. -Oxidation of different fatty acids in wild-type and transformed pxa1 pxa2 mutant cells.
Cells grown on oleatemediumwere incubatedwith 1-14C-labeled fatty acids, followed by -oxidation activity
measurements. Results are presented as% relative to the rate of oxidationbywild-type cells for each fatty acid.
Bars represent mean S.E. (n 3).
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60). In common with CTS, ALDP, PMP70, and TAP (trans-
porter associated with antigen processing) are insensitive to
vanadate, but susceptible to inhibition by metal fluorides
(61–63).
The ability of CTS to complement a pxa1 pxa2mutant for
growth on oleic acid and to support the -oxidation of a range
of fatty acids (C16:0-C24:0) provides further support for the
ability of CTS to handle a broad range of substrates, in contrast
to ALDP, which shows amarked preference for very long-chain
substrates (9). Evidence from yeast suggests that Pxa1/Pxa2p
transports FA-CoAs and not FA (10), suggesting, by extension,
that the same is also true for ALDP and CTS, because they
complement the pxa1 pxa2mutant (Ref. 9 and this study) and
the peroxisomal synthetase Faa2p is not required for metabo-
lism of fatty acids with chain lengths longer than C14 (2). Both
cytosolic and peroxisomal acyl-CoA synthetases exist inArabi-
dopsis (29, 64, 65) but genetic data imply that CTSmight trans-
port free acids and not CoAs. Arabidopsis mutants and trans-
genics in which peroxisomal acyl-CoA synthetases and
peroxisomal adenine nucleotide translocators are down-regu-
lated share the lipid mobilization defect of ctsmutants (29, 57,
58) and the peroxisomal acetyl-CoA synthetase mutant, acn1,
and the cts allele, acn2 are both impaired in acetate metabolism
(19, 66), suggesting that free acids must be activated in the per-
oxisome prior to -oxidation. Therefore, the precise nature of
theCTS substrates is of particular interest. As a number of ABC
transporters exhibit substrate-stimulated ATPase activity (46–
49, 67), we tested both FA and FA-CoA for effects on basal
ATPase activity. Comparison of the stimulation indices for free
acids and acyl-CoA esters indicated that CoAs gave a markedly
greater stimulation than the corresponding free FA. The non-
hydrolysable etheno-CoA species also stimulated basal ATPase,
providing evidence that the CoA ester, rather than the free FA
hydrolysis product is responsible for this effect.
Stimulation of CTS-dependent ATPase activity was ob-
served in the concentration range of 10–100 M FA-CoA. It is
noteworthy that higher concentrations (1000 M) of FA and
FA-CoAhad an inhibitory effect on the basal ATPase activity of
CTS (not shown), possibly due to a detergent effect. However,
the observation that 100 M of various non-ionic and anionic
detergents did not affect the basal ATPase activity of CTS (data
not shown) suggests that the effects observed at 100 M reflect
a specific interaction of the substrates with CTS. The critical
micelle concentrations of medium to long-chain acyl-CoAs are
reported to be in the range of 5–200 M depending on chain
length, degree of saturation, and the ionic strength of the buffer
(68). Below the critical micelle concentration, acyl-CoAs exist
in molecular solution, but above the critical micelle concentra-
tion, the concentration of free acyl-CoA is independent of the
total concentration. In mammalian cells, the total cellular acyl-
CoA concentration was reported to be in the range of 5–160
M, depending on the metabolic state of the cell, although the
majority of the acyl-CoA pool is likely to be protein-bound (68,
69). Acyl-CoA concentrations in plants are lower: in the range
of 3–6 M in developing Brassica napus embryos and in Ara-
bidopsis seedlings (70). The potential disparity between the
stimulatory concentration determined in this study and the
reported concentration of acyl-CoAs in plant cells possibly
reflects the differences between in vivo and in vitro conditions.
For FA and FA-CoA to interact with CTS, it is probable that
they partition into the peroxisomal membrane, where they
reach amuch higher local concentration (71–74). Nevertheless,
our data are consistent with those of Guimara˜es et al. (14), in
which FA-CoA (but not FA) provoked substrate-induced con-
formational changes in ALDP when supplied at 200 M.
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FIGURE 8. Effects of fatty acids and fatty acyl-CoAs on theATPase activity
of CTS. ATPase activity was measured in the presence of 10 or 100 M fatty
acids or fatty acyl-CoAs using peroxisomes (10 g of protein) isolated from
pxa1 cells transformed with CTS/pEL30 (black bars) or vector lacking insert
(openbars).A, ATPase activitiesmeasured in thepresenceor absenceof 10M
fatty acids/fatty acyl-CoAs; bars represent mean S.E. (n 3). B, the ATPase
activities obtained in A, or in a similar experiment performed using 100 M
fatty acids/fatty acyl-CoAs, were used to calculate the CTS ATPase activity
relative to that seen in the basal state in the absence of substrate (“stimula-
tion index”), according to the formula: (CTS expressing (stimulated) control
(stimulated))/(CTS (unstimulated)  control (unstimulated)). The basal
ATPase activity is defined as having a stimulation index of 1 (represented by a
broken line across the graph) and values above 1 indicate the degree of stim-
ulation relative to the basal ATPase activity of CTS. Black bars, 100 M sub-
strate; open bars, 10 M substrate.
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Although the stimulation of basal ATPase activity by the FA-
CoA species is consistent with CoA esters, rather than free FA,
being bona fide CTS substrates, other interpretations are pos-
sible: not all ABC transport substrates stimulate ATP hydroly-
sis and conversely, not all compounds that stimulate ATPase
activity are substrates (46, 47, 49, 75–77), therefore FA as
potential substrates cannot be excluded. Nevertheless, collec-
tively, our data support the notion that CTS is a transporter of
acyl-CoAs. It has beenproposed thatCTSmight cleave theCoA
moiety during transport, thus requiring its re-esterification
inside the peroxisome (29); alternatively, cleavage may be car-
ried out by peroxisomal thioesterases (78), which would agree
with both the biochemical and genetic data. Ultimately, trans-
port assays using purified, reconstituted CTS protein will be
essential to determine unequivocally the biochemical function
of this intriguing membrane protein. However, this study has
advanced our understanding of the function of CTS by identi-
fying potential substrates and developing a yeast expression
system that may prove useful for the expression, purification,
and reconstitution of CTS to enable testing of these substrates
via transport assays.
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